Liver Cirrhosis Epidemiology Review (2020-2024) and Forecast to 2034 - Which Country is More Prevalent for Liver Cirrhosis and Why?
05 déc. 2024 10h11 HE
|
Research and Markets
Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Liver Cirrhosis - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth...
Cirrhosis Market and Pipeline Insights, 2024: Analysis of Emerging Drugs GXHPC 1 (GWOXI Stem Cell Applied Technology), LPCN 1148 (Lipocine), and Belapectin (Galectin Therapeutics)
11 avr. 2024 11h06 HE
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Cirrhosis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...